$8.90
+0.0500 (+0.565%)
At Close: Jul 31, 2026
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
06:45am, Tuesday, 03'rd Dec 2024
GUANGZHOU, China, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequen
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
11:16pm, Thursday, 10'th Oct 2024
GUANGZHOU, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), an innovative company in the field of precision oncology, and D
Burning Rock Announces Changes to Management and Board of Directors
08:37am, Friday, 27'th Sep 2024
GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a company focused on the application of next generation seque
Burning Rock Reports Second Quarter 2024 Financial Results
11:59pm, Thursday, 22'nd Aug 2024
GUANGZHOU, China, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next gener
Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
02:21am, Monday, 19'th Aug 2024
GUANGZHOU, China, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (the “Company” or “Burning Rock”) announces that, on August 19, 2024, it intends to submit requests (a) to the
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
12:41am, Monday, 03'rd Jun 2024
GUANGZHOU, China, June 03, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next gener
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
03:42am, Thursday, 30'th May 2024
GUANGZHOU, China, May 30, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) has recently announced a collaboration with Bayer to
Burning Rock Reports First Quarter 2024 Financial Results
01:34am, Wednesday, 29'th May 2024
GUANGZHOU, China, May 29, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next genera
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
02:00am, Thursday, 23'rd May 2024
GUANGZHOU, China, May 23, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next genera
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
02:02am, Tuesday, 14'th May 2024
GUANGZHOU, China, May 14, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next genera
Burning Rock Publishes 2023 Annual Report on Form 20-F
03:30am, Monday, 29'th Apr 2024
GUANGZHOU, China, April 29, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next gene
Burning Rock Announces ADS Ratio Change
01:59am, Friday, 26'th Apr 2024
GUANGZHOU, China, April 26, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next gene
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
05:16pm, Thursday, 28'th Mar 2024
GUANGZHOU, China, March 28, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next gene
Burning Rock Announces Receipt of Notification from NASDAQ
01:03am, Thursday, 04'th Jan 2024
GUANGZHOU, China, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next gener
Burning Rock Announces Results of 2023 Annual General Meeting
09:35pm, Tuesday, 19'th Dec 2023
GUANGZHOU, China, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next gene
Sign In
Buy BNR